Medical Cannabis UK

Published: 27 October 2025
Last Updated: 24 July 2026
Last Reviewed: 24 July 2026
Author: Weed Supermarket Editorial Team

Public Opinion, Policy and Future Developments

The conversation surrounding cannabis in the United Kingdom has changed significantly over the past decade. Issues that were once discussed mainly within specialist medical or political circles are now the subject of wider public debate.

Topics including medical cannabis, decriminalisation, industrial hemp and cannabinoid research continue to evolve as new evidence emerges and public attitudes shift.

This article explores current trends, public opinion and the factors likely to influence cannabis policy in the years ahead.

Changing Public Opinion

Public attitudes towards cannabis have gradually changed in many countries, including the UK.

Recent opinion polling has suggested growing support for reforms relating to cannabis possession and wider discussion around drug policy.

Although public opinion is an important consideration for policymakers, changes to legislation depend upon numerous legal, scientific, medical and political factors.

Cannabis Use in the UK

Patterns of cannabis use have also changed over time.

Research has indicated that while overall usage rates have fluctuated, products available on the illicit market have generally become more potent than those commonly encountered several decades ago.

This increase in potency has become an important consideration within public health discussions.

High-Potency Cannabis and Public Health

Healthcare professionals continue to examine the potential impact of frequent use of high-THC cannabis.

Research has associated heavy use of high-potency cannabis with an increased risk of adverse outcomes in some individuals, including:

Anxiety.
Dependence.
Impaired cognition.
Psychotic disorders in susceptible individuals.

Researchers emphasise that risk varies considerably between individuals and depends on numerous biological and environmental factors.

Medical Cannabis in the UK

Since 2018, specialist clinicians in the UK have been able to prescribe certain cannabis-based medicinal products in limited clinical circumstances.

These medicines are primarily considered where conventional treatments have not provided sufficient benefit and prescribing decisions are made according to current clinical guidance.

Medical cannabis should not be confused with consumer CBD products, which are regulated under different legal frameworks.

Growth of the Medical Cannabis Sector

The UK medical cannabis sector has expanded considerably since legislative changes were introduced.

Industry reports indicate increasing numbers of patients are accessing specialist clinics for conditions including:

Chronic pain.
Treatment-resistant epilepsy.
Multiple sclerosis.
Certain other conditions where specialist clinicians consider cannabis-based medicines appropriate.

Most prescriptions continue to be issued through private healthcare providers, although discussion regarding wider access remains ongoing.

Industrial Hemp and Cannabinoids

Alongside medical cannabis, policymakers continue to consider the future of industrial hemp and hemp-derived cannabinoids.

Areas of discussion have included:

Hemp cultivation.
Agricultural regulation.
CBD product regulation.
Novel foods.
Consumer safety.

These discussions are separate from legislation governing controlled cannabis products.

Emerging Cannabinoids

Regulators have also increased scrutiny of newer cannabinoids and semi-synthetic compounds entering the consumer market.

As scientific understanding develops, governments continue to review whether existing legislation adequately addresses these products while balancing innovation with consumer protection.

Future Policy Considerations

Future cannabis policy in the UK is likely to be shaped by several competing priorities.

These include:

Patient access to evidence-based medicines.
Public health.
Mental health considerations.
Scientific research.
Consumer safety.
Law enforcement.
Economic considerations.

Any future legislative changes would require careful consideration of these factors alongside emerging scientific evidence.

The Importance of Research

Researchers continue to investigate cannabinoids across numerous medical conditions.

Areas receiving ongoing attention include:

Pain management.
Neurological disorders.
Epilepsy.
Sleep.
Anxiety.
Inflammation.

High-quality clinical trials remain essential for determining which cannabinoid medicines may be effective, for whom, and under what circumstances.

Learn more in our guide explaining the CBD Entourage Effect.

Related Guides

Frequently Asked Questions

Is medical cannabis legal in the UK?

Yes. Certain cannabis-based medicinal products may be prescribed by specialist clinicians in limited clinical circumstances under UK law.

Is recreational cannabis legal?

No. Cannabis containing controlled amounts of THC remains a controlled drug under UK legislation except in specific lawful circumstances.

Is public opinion changing?

Recent surveys suggest public attitudes towards cannabis policy have evolved, although opinions remain divided and legislation has not changed accordingly.

Can anyone obtain medical cannabis?

No. Prescription decisions are made by appropriately qualified specialist clinicians based on individual clinical circumstances.

Is CBD the same as medical cannabis?

No. Consumer CBD products and prescription cannabis-based medicines are different product categories regulated under different legal frameworks.

Will cannabis laws change in the future?

Future legislation cannot be predicted. Any changes would depend upon government policy, scientific evidence, public consultation and parliamentary processes.

Final Thoughts

Cannabis policy in the United Kingdom continues to evolve alongside advances in medical research, changing public attitudes and ongoing discussions about public health.

While medical cannabis has become an established part of specialist healthcare for some patients, broader questions surrounding regulation, access and harm reduction remain the subject of active debate.

As new evidence emerges, informed discussion based on high-quality research will remain essential for shaping future policy and clinical practice.

Compliance Statement

This article is provided for educational and informational purposes only. It discusses developments in UK cannabis policy, public opinion and medical research and should not be interpreted as legal or medical advice. References to medical cannabis relate solely to prescription cannabis-based medicinal products prescribed in accordance with UK law.